Market Research Reports- Consulting Analysis Crystal Market Research Diabetic Retinopathy Market by Type and Management | Page 2

patient population, increasing healthcare spending, and increased focus of international players on
emerging markets owing to growing preference for advanced healthcare facilities and rising disposable
income of people.
Diabetic retinopathy market is highly competitive in nature with the presence of large number of players
such as Bayer AG, F. Hoffmann-La Roche, Allergan plc, Alimera Sciences, Novartis International AG,
Pfizer, Regeneron Pharmaceuticals Inc., Ampio Pharmaceuticals., Abbott Laboratories, and Valeant
Pharmaceutical.
Request a sample copy of Diabetic Retinopathy Market Research Report @
http://www.crystalmarketresearch.com/report-sample/HC0622
Key Findings of the Research Study:





Laser surgery segment occupied more than two-fifth of the global market in 2016, due to high
adoption of this technique for the treatment of diabetic retinopathy.
Proliferative retinopathy occupied largest share of the global diabetic retinopathy market in 2016,
due to rising geriatric population rapidly moving towards proliferative stage of retinopathy.
U.S. dominated the NorthAmerica market in 2016, due to high market penetration of drugs such
as Avastinand Eylea.
Europe occupied the second largest share of the global market in 2016. This can be attributed to
rise in diabetic population, high adoption of technologically advanced products, and rise in
demand for early screening techniques.
Asia-Pacific is expected to witness high growth rate during the forecast period due to large
diabetic population base and increasing awareness about diabetes and availability of treatment
options.
Inquire more about this report at: http://www.crystalmarketresearch.com/send-an-
enquiry/HC0622
Diabetic Retinopathy Market is segmented as follows –
By Type:
 Proliferative Diabetic Retinopathy
 Diabetic Macular Edema
By Management:

Anti VEGF Drugs